Financial intelligence for Asia's healthcare markets
 
 
Remember me:


News articles    

Beijing-based China Jo-Jo Drugstores has reported a small net profit of $456,000 for the third quarter of its 2020 fiscal year, ending 31 December 2019, compared to a net loss of $2.2 million reported for Q3 2109.
The head of a leading hospital in Wuhan, the epicentre of a coronavirus outbreak, has died of the disease, according to China’s state television.
New Delhi-based Hempstreet, a research-to-retail healthcare start-up that focuses on cannabis uses in Ayurvedic medicine, has raised $1 million in pre-series A funding.
Sydney-based George Clinical, a global clinical research organisation, has appointed James as chief executive, replacing Glenn Kerkhof who becomes chairman.
Thomson Medical Group’s pre-tax profit for 2019 was $14.7 million, down 33% from the $22 million reported for 2018.
Ping An Healthcare and Technology Company has announced a 2019 loss of ¥746.7 million ($107.1 million), which compares to a net loss of ¥913.1 million announced for 2018.
Technology company Vakrangee has formed an alliance with vHealth by Aetna, which is owned by Aetna, a CVS Health company, to offer a combination of telemedicine services and privileged access to its nationwide network of hospitals and clinics.
GenapSys has launched its gene sequencer in the Asia-Pacific region, including in South Korea, Singapore, Japan, and the fast-growing Chinese gene sequencing market, which is currently at the epicenter of the Coronavirus outbreak.
Novaerus, an Irish company that manufactures and sells patented medical-grade, clean air solutions, has partnered with seven established distributors across China.
Start-up HiDoc is to open telehealth kiosks in the new Ola luxury condominiums being built in Singapore, enabling residents to have virtual medical consultations with doctors.
12345678910...

Subscribe to our news RSS feed Get the RSS for HealthInvestor Asia



Civica

AON


Markets

The IPO market in Hong Kong is hotting up again and it looks as though 2019 is going to be as busy with biotech company floats as last year was.


Podcasts

Analysis

HealthInvestor Asia twitter feed



Podcasts

HealthInvestor UK